Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus
about
Capsule production and growth phase influence binding of complement to Staphylococcus aureusThe zwitterionic cell wall teichoic acid of Staphylococcus aureus provokes skin abscesses in mice by a novel CD4+ T-cell-dependent mechanism.Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin.Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses.Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States.Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolatesPromoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus.Staphylococcus aureus cap5P encodes a UDP-N-acetylglucosamine 2-epimerase with functional redundancy.Functional analysis of the Staphylococcus aureus collagen adhesin B domainDevelopment and characterization of a Staphylococcus aureus nasal colonization model in mice.Acute septic arthritis.Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA.Overproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence.Staphylococcus aureus gene expression in a rat model of infective endocarditis.Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strainsHeterogeneity of cell-associated CP5 expression on Staphylococcus aureus strains demonstrated by flow cytometry.Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis.Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines.A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.Molecular characterization and transcriptional analysis of type 8 capsule genes in Staphylococcus aureusStaphylococcus aureus capsular polysaccharides.Genetic analysis of type 5 capsular polysaccharide expression by Staphylococcus aureus.Dynamic in vivo mutations within the ica operon during persistence of Staphylococcus aureus in the airways of cystic fibrosis patients.Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice.Capsule expression and genotypic differences among Staphylococcus aureus isolates from patients with chronic or acute osteomyelitis.MgrA activates expression of capsule genes, but not the α-toxin gene in experimental Staphylococcus aureus endocarditis.Regulation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides by CO(2).Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase.Synthesis of microcapsule by Staphylococcus aureus is not responsive to environmental phosphate concentrations.Conservation, surface exposure, and in vivo expression of the Frp family of iron-regulated cell wall proteins in Staphylococcus aureus.Salicylic acid diminishes Staphylococcus aureus capsular polysaccharide type 5 expressionRespiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus.Virulence factors among gram-positive bacteria in experimental endocarditis.Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.Fur is required for the activation of virulence gene expression through the induction of the sae regulatory system in Staphylococcus aureus.Natural polyreactive IgA antibodies coat the intestinal microbiota.
P2860
Q33552644-2908B066-D79A-474E-8FEB-DDF61A5D98A9Q33719517-BA63181A-4F2A-46E1-B0AA-5ACBC9D9F365Q33767412-0AD0FB2F-D4B3-41F1-B4D8-15B727DB1005Q33788238-504B2D98-8D7B-4F00-AF82-CE2D41EBC7EAQ33795274-D29C9F35-DC0E-4163-98B8-0C63F1B418F2Q33965596-CD5D59AD-659D-46BE-A24F-E5E123BAC413Q33968870-B916E160-912F-41FD-A2FC-104417706789Q33978642-AC247EDD-70DF-463C-9CDA-B3134317F10AQ33991770-6D7307CF-F9EE-4F48-81D2-35F310D229E8Q33992673-18786E50-E917-4677-A671-B379286F78E2Q34001400-D08CAE01-1310-45D4-8DED-990752CC8193Q34001970-95459B45-4D84-4F4D-86C7-7F63CEDFA0AEQ34102880-F3680158-A0F5-4233-A964-1240B7A04FBEQ34116833-D9890FDB-0FED-4B27-A93E-F6C191D704BAQ34126226-91EC52B7-721E-40C5-BFDA-8DCA34178EA9Q34491802-CBF5B32E-ACBD-4103-9D6F-69F069312CC6Q35224198-725D5AF0-D27C-41FD-ABBF-E2BBEB372E87Q35229468-8ACD791E-184D-403C-9871-F2AA8B949B8FQ35382289-689D6D4F-0DA7-4862-8443-69F128C213C5Q35401023-D7E7F3BD-D14A-488A-BC06-44A187ACDB59Q35489404-F0D50406-E253-42C8-AF94-6AC84170DBFFQ35620548-71F2BC53-22C0-4BFA-B4A1-6B63623C7038Q35630504-FEF136F2-80D9-4190-8E10-69E8F70DCF6CQ35967916-6D76C8D6-B3E1-4A16-9EEC-69BB179EBEDCQ36208337-A459FCC4-2491-4540-97AA-0746934ED6A7Q36974423-BFDF5547-43CB-4A02-8F5A-D3AEA9A034ABQ37191404-890F19EB-C4D3-4FD1-8E28-472EE3475CD8Q37272332-8B2EECEC-64CC-4C90-BEF1-12755849D8D3Q39504396-F2FB2688-5CCB-4123-836B-DA16E1441BC8Q39537626-D09E56CE-67F6-4D1B-A745-BF58AC000E9DQ39572650-0185190D-1093-4F44-A35F-7FCEFFD1CE5AQ39654940-63B1113E-AD34-445E-BBB6-1CE988C3385EQ39763551-76A7FDAD-D4DF-4DA2-A364-8D8FE2DEA7F3Q39825299-449E8D33-B73D-454D-A025-813875E8666EQ39860412-941B5B6D-13A3-4E7F-B357-AEC02947508CQ40245675-68482B7E-A556-428B-AAF7-4100813302ACQ40416064-F5ECBC8F-C2B6-4DE7-8742-2B97C88209D0Q41355944-A8693231-481E-476A-9D23-C0058F9FC761Q46296384-87A70B49-40E8-4073-8842-E2F19631FB75
P2860
Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Effects of in vitro and in viv ...... aride by Staphylococcus aureus
@ast
Effects of in vitro and in viv ...... aride by Staphylococcus aureus
@en
type
label
Effects of in vitro and in viv ...... aride by Staphylococcus aureus
@ast
Effects of in vitro and in viv ...... aride by Staphylococcus aureus
@en
prefLabel
Effects of in vitro and in viv ...... aride by Staphylococcus aureus
@ast
Effects of in vitro and in viv ...... aride by Staphylococcus aureus
@en
P2093
P2860
P1476
Effects of in vitro and in viv ...... aride by Staphylococcus aureus
@en
P2093
P2860
P304
P407
P577
1993-05-01T00:00:00Z